Literature DB >> 24629219

Ventriculoarterial coupling in palliated hypoplastic left heart syndrome: Noninvasive assessment of the effects of surgical arch reconstruction and shunt type.

Giovanni Biglino1, Alessandro Giardini2, Hopewell N Ntsinjana2, Silvia Schievano2, Tain-Yen Hsia2, Andrew M Taylor2.   

Abstract

OBJECTIVE: To assess the coupling efficiency in hypoplastic left heart syndrome, considering the effect of surgical arch reconstruction and the shunt type received during the Norwood procedure.
METHODS: Ventriculoarterial coupling was assessed before Fontan completion in 32 patients with hypoplastic left heart syndrome (19 modified Blalock-Taussig and 13 Sano shunts at stage 1). Cardiovascular magnetic resonance data were analyzed, deriving functional parameters and 3-dimensional volumes. Dimensional indexes were computed from 3-dimensional data sets as the area ratio of the isthmus to the descending aorta (Risthmus) and the isthmus to surgically enlarged transverse arch (Rarch). Wave intensity was calculated from cardiac magnetic resonance, using the peaks of the forward compression and expansion waves in early and late systole as surrogate indicators of ventriculoarterial coupling.
RESULTS: Aortic distensibility (3.6±2.7×10(-3) 1/mm Hg) was not associated with the time elapsed from stage 1 palliation (P=.94), suggesting an early loss of elasticity that did not progress thereafter. Risthmus was 1.0±0.4, and Rarch was 0.3±0.1, indicating the dilated reconstructed arch was the main anatomic feature. The forward compression wave correlated significantly with Rarch (R2=0.23, P=.006) but not with Risthmus (R2<0.01, P=.63). Patients with a reduced ejection fraction exhibited a larger ventricular mass (R2=0.28, P=.003). The Sano shunt patients had a lower ejection fraction (51%±6% vs 57%±6%, P=.02); however, neither the forward compression nor expansion wave varied significantly between shunt type or the other functional parameters.
CONCLUSIONS: Ventriculoarterial coupling in operated hypoplastic left heart syndrome was affected by aortic arch size mismatch but not by the type of shunt placed at the Norwood operation.
Copyright © 2014 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24629219     DOI: 10.1016/j.jtcvs.2014.02.012

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  5 in total

1.  Assessing Single Ventricle Function in the Fontan Circulation using Wave Intensity Analysis.

Authors:  John Valdovinos; Nicolas Eng; Matthew Russell; Samuel Zahn; Daniel S Levi
Journal:  Pediatr Cardiol       Date:  2021-01-29       Impact factor: 1.655

2.  Abnormal torsion and helical flow patterns of the neo-aorta in hypoplastic left heart syndrome assessed with 4D-flow MRI.

Authors:  Dominik Daniel Gabbert; Patrick Trotz; Arash Kheradvar; Michael Jerosch-Herold; Jens Scheewe; Hans-Heiner Kramer; Inga Voges; Carsten Rickers
Journal:  Cardiovasc Diagn Ther       Date:  2021-12

3.  Unlocking the Non-invasive Assessment of Conduit and Reservoir Function in the Aorta : The Obstructive Descending Aorta in HLHS.

Authors:  Adelaide de Vecchi; Alessandro Faraci; Joao Filipe Fernandes; David Marlevi; Hannah Bellsham-Revell; Tarique Hussain; Nidhin Laji; Bram Ruijsink; James Wong; Reza Razavi; David Anderson; Caner Salih; Kuberan Pushparajah; David Nordsletten; Pablo Lamata
Journal:  J Cardiovasc Transl Res       Date:  2022-02-23       Impact factor: 4.132

4.  Does the size of pulmonary artery impact on recoarctation of the aorta after the Norwood procedure without patch?

Authors:  Yasuyuki Kobayashi; Yasuhiro Kotani; Takuya Kawabata; Yosuke Kuroko; Shunji Sano; Shingo Kasahara
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-10-29

5.  Adverse fibrosis remodeling and aortopulmonary collateral flow are associated with poor Fontan outcomes.

Authors:  Andrea Pisesky; Marjolein J E Reichert; Charlotte de Lange; Mike Seed; Shi-Joon Yoo; Christopher Z Lam; Lars Grosse-Wortmann
Journal:  J Cardiovasc Magn Reson       Date:  2021-11-15       Impact factor: 5.364

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.